Clinical Liver Disease

Treatment can be deferred in chronic HBV patients with inactive or mild liver disease without risk of liver disease progression, while patients with active or advanced liver disease should be treated. Dr. Papatheodoridis reviews approaches to classifying patients and how to determine the most appropriate treatment plans.